Literature DB >> 24996793

Distinct perfusion patterns in Alzheimer's disease, frontotemporal dementia and dementia with Lewy bodies.

Maja A A Binnewijzend1, Joost P A Kuijer, Wiesje M van der Flier, Marije R Benedictus, Christiane M Möller, Yolande A L Pijnenburg, Afina W Lemstra, Niels D Prins, Mike P Wattjes, Bart N M van Berckel, Philip Scheltens, Frederik Barkhof.   

Abstract

OBJECTIVES: To compare pseudo-continuous arterial spin-labelled (PCASL) magnetic resonance imaging (MRI) measured quantitative cerebral blood flow (CBF) of patients with frontotemporal dementia (FTD), dementia with Lewy Bodies (DLB), Alzheimer's disease (AD) and controls, in a region of interest (ROI) and voxel-wise fashion.
METHODS: We analysed whole-brain 3D fast-spin-echo PCASL images of 20 FTD patients, 14 DLB patients, 48 AD patients and 50 controls from the Amsterdam Dementia Cohort. Regional CBF patterns were compared using analyses of variance for repeated measures. Permutation tests were used for voxel-wise comparisons. Analyses were performed using uncorrected and partial volume corrected (PVC) maps. All analyses were corrected for age and sex.
RESULTS: There was an interaction between diagnosis and region (p < 0.001), implying differences in regional CBF changes between diagnostic groups. In AD patients, CBF was decreased in all supratentorial regions, most prominently so in the posterior regions. DLB patients showed lowest CBF values throughout the brain, but temporal CBF was preserved. Supratentorial PVC cortical CBF values were lowest in the frontal lobes in FTD patients, and in the temporal lobes in AD patients.
CONCLUSIONS: Patients with AD, FTD and DLB display distinct patterns of quantitative regional CBF changes. 3D-PCASL may provide additional value in the workup of dementia patients. KEY POINTS: Patterns of regional CBF changes differ between AD, FTD and DLB patients. CBF is lower throughout the brain in DLB than AD and FTD. 3D-PCASL MRI is a potential non-invasive and easily accessible alternative to FDG-PET. 3D-PCASL MRI may be of additional value in the workup of dementia.

Entities:  

Mesh:

Year:  2014        PMID: 24996793     DOI: 10.1007/s00330-014-3172-3

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  40 in total

1.  Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?

Authors:  Tamara G Fong; Sharon K Inouye; Weiying Dai; Daniel Z Press; David C Alsop
Journal:  Brain Imaging Behav       Date:  2011-03       Impact factor: 3.978

Review 2.  Review: does measurement of regional cerebral blood flow reflect synaptic activity? Implications for PET and fMRI.

Authors:  M Jueptner; C Weiller
Journal:  Neuroimage       Date:  1995-06       Impact factor: 6.556

3.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

4.  Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT.

Authors:  Soichiro Shimizu; Haruo Hanyu; Hidekazu Kanetaka; Toshihiko Iwamoto; Kiyoshi Koizumi; Kimihiko Abe
Journal:  Dement Geriatr Cogn Disord       Date:  2005-04-12       Impact factor: 2.959

5.  Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity.

Authors:  Maja A A Binnewijzend; Joost P A Kuijer; Marije R Benedictus; Wiesje M van der Flier; Alle Meije Wink; Mike P Wattjes; Bart N M van Berckel; Philip Scheltens; Frederik Barkhof
Journal:  Radiology       Date:  2012-12-13       Impact factor: 11.105

6.  Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease.

Authors:  R L Albin; S Minoshima; C J D'Amato; K A Frey; D A Kuhl; A A Sima
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

7.  A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.

Authors:  Sean J Colloby; John D Fenwick; E David Williams; Sean M Paling; Kyriakos Lobotesis; Clive Ballard; Ian McKeith; John T O'Brien
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03-05       Impact factor: 9.236

8.  Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.

Authors:  Mona K Beyer; Jan P Larsen; Dag Aarsland
Journal:  Neurology       Date:  2007-08-21       Impact factor: 9.910

9.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

10.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop.

Authors:  Ian G McKeith
Journal:  J Alzheimers Dis       Date:  2006       Impact factor: 4.472

View more
  31 in total

Review 1.  PET/MRI of central nervous system: current status and future perspective.

Authors:  Zhen Lu Yang; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2016-01-15       Impact factor: 5.315

Review 2.  A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review.

Authors:  Candice E Van Skike; Veronica Galvan
Journal:  Gerontology       Date:  2018-01-11       Impact factor: 5.140

3.  Recent imaging advances in neurology.

Authors:  Lorenzo Rocchi; Flavia Niccolini; Marios Politis
Journal:  J Neurol       Date:  2015-03-26       Impact factor: 4.849

4.  Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin?

Authors:  Sander C J Verfaillie; Sofie M Adriaanse; Maja A A Binnewijzend; Marije R Benedictus; Rik Ossenkoppele; Mike P Wattjes; Yolande A L Pijnenburg; Wiesje M van der Flier; Adriaan A Lammertsma; Joost P A Kuijer; Ronald Boellaard; Philip Scheltens; Bart N M van Berckel; Frederik Barkhof
Journal:  Eur Radiol       Date:  2015-04-22       Impact factor: 5.315

5.  Early-stage differentiation between presenile Alzheimer's disease and frontotemporal dementia using arterial spin labeling MRI.

Authors:  Rebecca M E Steketee; Esther E Bron; Rozanna Meijboom; Gavin C Houston; Stefan Klein; Henri J M M Mutsaerts; Carolina P Mendez Orellana; Frank Jan de Jong; John C van Swieten; Aad van der Lugt; Marion Smits
Journal:  Eur Radiol       Date:  2015-05-31       Impact factor: 5.315

6.  Quantitative multimodal multiparametric imaging in Alzheimer's disease.

Authors:  Qian Zhao; Xueqi Chen; Yun Zhou
Journal:  Brain Inform       Date:  2016-01-08

7.  Brain perfusion in dementia with Lewy bodies and Alzheimer's disease: an arterial spin labeling MRI study on prodromal and mild dementia stages.

Authors:  Daniel Roquet; Marion Sourty; Anne Botzung; Jean-Paul Armspach; Frédéric Blanc
Journal:  Alzheimers Res Ther       Date:  2016-07-12       Impact factor: 6.982

Review 8.  Imaging and fluid biomarkers in frontotemporal dementia.

Authors:  Lieke H Meeter; Laura Donker Kaat; Jonathan D Rohrer; John C van Swieten
Journal:  Nat Rev Neurol       Date:  2017-06-16       Impact factor: 42.937

9.  Neural correlates of attention-executive dysfunction in lewy body dementia and Alzheimer's disease.

Authors:  Michael Firbank; Xenia Kobeleva; George Cherry; Alison Killen; Peter Gallagher; David J Burn; Alan J Thomas; John T O'Brien; John-Paul Taylor
Journal:  Hum Brain Mapp       Date:  2015-12-26       Impact factor: 5.038

Review 10.  Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease.

Authors:  Michael J Knight; Bryony McCann; Risto A Kauppinen; Elizabeth J Coulthard
Journal:  Front Aging Neurosci       Date:  2016-06-16       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.